United Therapeutics Pipeline

United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR.

United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses.

United Therapeutics Corp (NASDAQ:UTHR) Chairperson & CEO Martine Rothblatt has sold 30,000 shares of the company on March 22, 2024, according to a recent SEC ...

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

United Therapeutics Corporation is a publicly traded company delivering advanced pharmaceutical therapies and organ transplant technology.

United Therapeutics is a. Public Benefit Corporation. Since our launch, we have operated with a patient-driven mission, strong values, and long-term vision.

為優化網站服務，鉅亨網使用Cookie來改善使用者體驗。當您繼續使用本網站即表示您同意Cookies政策與隱私權政策。

United Therapeutics Corporation (UTHR). $237.900.97(0.41%).

United Therapeutics Corporation · UTHR ; 聯合治療公司 · Nasdaq ; 1000 Spring St,Silver Spring,Maryland 20910,United States Of America · http://www.unither.com.